The most frustrating part about MASLD is that this serious illness can be reversed with early identification and treatment.

A drug that outperforms placebo in helping people to lose weight is one of a growing number of next-generation obesity drugs being produced in ... the drug lost up to 13.8 kilograms over 48 weeks of ...

Introduction Obesity treatment guidelines suggest moderate-intensity continuous training (MICT), but the patient’s compliance to this indication remains low. High-intensity interval training (HIIT) is ...

A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with ...

Researchers found that once-monthly maridebart cafraglutide led to substantial weight loss and improved glycemic control in ...

Objective This report from the NORD-STAR (Nordic Rheumatic Diseases Strategy Trials and Registries) trial aimed to determine if obesity is associated with response to conventional and biological ...

Slashing health care support for low-income Californians isn’t just a budget decision, it is a public health crisis in the ...

As rates of MASLD, which is linked to obesity and diabetes, rise, new therapies have emerged, but better diagnostic and ...

For instance, survivors with cancers related to obesity often face higher risks for cancer recurrence and death—not just from ...

Eli Lilly & Co.'s experimental weight loss pill helped patients shed pounds without serious side effects in a clinical trial, ...

More than 90% of patients achieved clinically meaningful weight reduction compared to placebo in a phase 3 trial of ecnoglutide.